Src-homology domain 2 containing protein tyrosine phosphatase-1 (SHP-1) directly binds to proto-oncogene tyrosine-protein kinase Src (c-Src) and promotes the transcriptional activation of connexin 43 (Cx43)

References

• Femia G, Fetahovic T, Shetty P, et al. Novel oral anticoagulants in direct current cardioversion for atrial fibrillation [J]. Heart Lung Circ. 2018;27(7):798–803.
   PubMed Web of Science ®Google Scholar
• Benamer S, Lusty D, Everington T. Dabigatran versus warfarin for direct current cardioversion in atrial fibrillation [J]. Cardiol Ther. 2016;5(2):215–221.
   PubMedGoogle Scholar
• Bellew SD, Moman R, Lohse CM, et al. Validation of a decision rule for selective TSH screening in atrial fibrillation [J]. West J Emerg Med. 2015;16(1):195–202.
   PubMedGoogle Scholar
• Jiang Y-F, Chen M, Zhang -N-N, et al. Association between KCNE1 G38S gene polymorphism and risk of atrial fibrillation: a PRISMA-compliant meta-analysis [J]. Medicine (Baltimore). 2017;96(25):e7253.
   PubMed Web of Science ®Google Scholar
• Shu C, Huang W, Zeng Z, et al. Connexin 43 is involved in the sympathetic atrial fibrillation in canine and canine atrial myocytes [J]. Anatol J Cardiol. 2017;18(1):3–9.
   PubMed Web of Science ®Google Scholar
• Carotenuto F, Teodori L, Maccari AM, et al. Turning regenerative technologies into treatment to repair myocardial injuries [J]. J Cell Mol Med. 2020;24(5):2704–2716.
   PubMed Web of Science ®Google Scholar
• Bhardwaj S, Srivastava N, Sudan R, et al. Leishmania interferes with host cell signaling to devise a survival strategy [J]. J Biomed Biotechnol. 2010;2010:109189.
   PubMedGoogle Scholar
• Karki R, Zhang Y, Igwe OJ. Activation of c-Src: a hub for exogenous pro-oxidant-mediated activation of Toll-like receptor 4 signaling [J]. Free Radic Biol Med. 2014;71:256–269.
   PubMed Web of Science ®Google Scholar
• Del Rincón SV, Rogers J, Widschwendter M, et al. Development and validation of a method for profiling post-translational modification activities using protein microarrays [J]. PloS one. 2010;5(6):e11332.
   PubMed Web of Science ®Google Scholar
• Feijóo-Bandín S, Aragón-Herrera A, Moraña-Fernández S, et al. Adipokines and inflammation: focus on cardiovascular diseases [J]. Int J Mol Sci. 2020;21(20):7711.
   PubMed Web of Science ®Google Scholar
• Rutledge CA, Ng FS, Sulkin MS, et al. c-Src kinase inhibition reduces arrhythmia inducibility and connexin43 dysregulation after myocardial infarction [J]. J Am Coll Cardiol. 2014;63(9):928–934.
   PubMed Web of Science ®Google Scholar
• Liu Y, Lu L, Cao L, et al. Role of SHP-1 in angiotensin-(1-7)antagonizing angiotensin II-induced connexin remodeling in mouse HL-1 cardiomyocytes [J]. J third mil med univ. 2018;40(13): 1179–1184.
   Google Scholar
• Lu L, Cao L, Liu Y, et al. Angiotensin (ang) 1-7 inhibits ang II-induced atrial fibrosis through regulating the interaction of proto-oncogene tyrosine-protein kinase Src (c-Src) and Src homology region 2 domain-containing phosphatase-1 (SHP-1)) [J]. Bioengineered. 2021;12(2):10823–10836.
   PubMed Web of Science ®Google Scholar
• Mahmood T, Yang PC. Western blot: technique, theory, and trouble shooting [J]. N Am J Med Sci. 2012;4(9):429–434.
   PubMedGoogle Scholar
• Pesce M, Ferrone A, Rizzuto A, et al. The SHP-1 expression is associated with cytokines and psychopathological status in unmedicated first episode schizophrenia patients [J]. Brain Behav Immun. 2014;41:251–260.
   PubMed Web of Science ®Google Scholar
• Im K, Mareninov S, Diaz MFP, et al. An introduction to performing immunofluorescence staining [J]. Methods Mol Biol. 2019;1897:299–311.
   PubMedGoogle Scholar
• Dong L, Huang J, Zu P, et al. Transcription factor 3 (TCF3) combined with histone deacetylase 3 (HDAC3) down-regulates microRNA-101 to promote Burkitt lymphoma cell proliferation and inhibit apoptosis [J]. Bioengineered. 2021;12(1):7995–8005.
   PubMed Web of Science ®Google Scholar
• Huang K, Tang Y. SChLAP1 promotes prostate cancer development through interacting with EZH2 to mediate promoter methylation modification of multiple miRNAs of chromosome 5 with a DNMT3a-feedback loop [J]. Cell Death Dis. 2021;12(2):188.
   PubMed Web of Science ®Google Scholar
• Chen W, Wang H, Liu J, et al. Interference of KLF9 relieved the development of gestational diabetes mellitus by upregulating DDAH2 [J]. Bioengineered. 2021;13(1): 395–406.
   Web of Science ®Google Scholar
• Jiang Z, Chen H, Su M, et al. MicroRNA-23a-3p influences the molecular mechanism of gastric cancer cells via CCL22/PI3K/Akt axis [J]. Bioengineered. 2021;12(2):11277–11287.
   PubMed Web of Science ®Google Scholar
• Himelman E, Lillo MA, Nouet J, et al. Prevention of connexin-43 remodeling protects against Duchenne muscular dystrophy cardiomyopathy [J]. J Clin Invest. 2020;130(4):1713–1727.
   PubMed Web of Science ®Google Scholar
• Yang BF, Shi JZ, Li J, et al. Expression of Cx43 and Cx45 in cardiomyocytes of an overworked rat model [J]. Fa Yi Xue Za Zhi. 2019;35(5):567–571.
   PubMedGoogle Scholar
• Schultz F, Swiatlowska P, Alvarez-Laviada A, et al. Cardiomyocyte-myofibroblast contact dynamism is modulated by connexin-43 [J]. Faseb J. 2019;33(9):10453–10468.
   PubMed Web of Science ®Google Scholar
• Lissoni A, Hulpiau P, Martins-Marques T, et al. RyR2 regulates Cx43 hemichannel intracellular Ca2+-dependent activation in cardiomyocytes [J]. Cardiovasc Res. 2021;117(1):123–136.
   PubMed Web of Science ®Google Scholar
• Xue J, Yan X, Yang Y, et al. Connexin 43 dephosphorylation contributes to arrhythmias and cardiomyocyte apoptosis in ischemia/reperfusion hearts [J]. Basic Res Cardiol. 2019;114(5):40.
   PubMed Web of Science ®Google Scholar
• Ghazizadeh Z, Kiviniemi T, Olafsson S, et al. Metastable atrial state underlies the primary genetic substrate for MYL4 mutation-associated atrial fibrillation [J]. Circulation. 2020;141(4):301–312.
   PubMed Web of Science ®Google Scholar
• Luo B, Yan Y, Zeng Z, et al. Connexin 43 reduces susceptibility to sympathetic atrial fibrillation [J]. Int J Mol Med. 2018;42(2):1125–1133.
   PubMed Web of Science ®Google Scholar
• Peng K, Tian X, Qian Y, et al. Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II [J]. J Cell Mol Med. 2016;20(3):482–494.
   PubMed Web of Science ®Google Scholar
• Atef ME, Anand-Srivastava MB, Quintas LEM. Role of PKCδ in enhanced expression of Gqα/PLCβ1 proteins and VSMC hypertrophy in spontaneously hypertensive rats [J]. PloS one. 2016;11(7):e0157955.
   PubMed Web of Science ®Google Scholar
• Tao X, Fan J, Kao G, et al. Angiotensin-(1-7) attenuates angiotensin II-induced signalling associated with activation of a tyrosine phosphatase in Sprague-Dawley rats cardiac fibroblasts [J]. Biol Cell. 2014;106(6):182–192.
   PubMed Web of Science ®Google Scholar
• Alzayadneh EM, Chappell MC. Angiotensin-(1-7) abolishes AGE-induced cellular hypertrophy and myofibroblast transformation via inhibition of ERK1/2 [J]. Cell Signal. 2014;26(12):3027–3035.
   PubMed Web of Science ®Google Scholar
• Ferreira AJ, Murça TM, Fraga-Silva RA, et al. New cardiovascular and pulmonary therapeutic strategies based on the angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor axis [J]. Int J Hypertens. 2012;2012:147825.
   PubMedGoogle Scholar
• Roberts JD, Dewland TA, Glidden DV, et al. Impact of genetic variants on the upstream efficacy of renin-angiotensin system inhibitors for the prevention of atrial fibrillation [J]. Am Heart J. 2016;175:9–17.
   PubMed Web of Science ®Google Scholar
• Kokubu N, Yuda S, Tsuchihashi K, et al. Noninvasive assessment of left atrial function by strain rate imaging in patients with hypertension: a possible beneficial effect of renin-angiotensin system inhibition on left atrial function [J]. Hypertens Res. 2007;30(1):13–21.
   PubMed Web of Science ®Google Scholar
• Yu J, Wu Y, Zhang Y, et al. Role of ACE2-Ang (1-7)-Mas receptor axis in heart failure with preserved ejection fraction with hypertension] [J. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018;43(7):738–746.
   PubMedGoogle Scholar